TY  - JOUR
AU  - Puig-Domingo, Manuel
AU  - Soto, Alfonso
AU  - Venegas, Eva
AU  - Vilchez, Ricardo
AU  - Blanco, Concepción
AU  - Cordido, Fernando
AU  - Lucas, Tomás
AU  - Marazuela, Mónica
AU  - Casany, Rosa
AU  - Cuatrecasas, Guillem
AU  - Fajardo, Carmen
AU  - Gálvez, María Ángeles
AU  - Maraver, Silvia
AU  - Martín, Tomás
AU  - Romero, Enrique
AU  - Paja, Miguel
AU  - Picó, Antonio
AU  - Bernabeu, Ignacio
AU  - Resmini, Eugenia
AU  - ACROCOMB study group
PY  - 2016
DO  - 10.1016/j.endonu.2016.05.010
UR  - http://hdl.handle.net/10668/10301
T2  - Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
AB  - To describe real-world use of lanreotide combination therapy for acromegaly. ACROCOMB is a retrospective observational Spanish study of patients with active acromegaly treated with lanreotide combination therapy between 2006 and 2011. 108 patients...
LA  - en
KW  - Acromegalia
KW  - Acromegaly
KW  - Análogos de la somatostatina
KW  - Cabergolina
KW  - Cabergoline
KW  - IGF-I
KW  - Lanreotida
KW  - Lanreotide
KW  - Pegvisomant
KW  - Somatostatin analogues
KW  - Acromegaly
KW  - Cabergoline
KW  - Dopamine Agonists
KW  - Drug Therapy, Combination
KW  - Ergolines
KW  - Human Growth Hormone
KW  - Humans
KW  - Insulin-Like Growth Factor I
KW  - Peptides, Cyclic
KW  - Retrospective Studies
KW  - Somatostatin
TI  - Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study.
TY  - research article
VL  - 63
ER  -